Content area
Full Text
THE YEAR 2008 PROVES TO BE A good year for the Malaysia's biotechnology industry with many significant achievements.
Datuk Iskandar Mizal Mahmood, Chief Executive Officer of Malaysian Biotechnology Corporation (BiotechCorp), the lead development agency for the biotech industry in Malaysia, announces that 12 firms out of 73 BioNexus companies turned in a strong performance with a total unaudited net profit of RM28 million over a period of just two years.
`In addition, two of these BioNexus firms have also been slated for listing on the London Stock Exchange and on the Mesdaq respectively,' he adds.
The industry also witness the launch of the BioNexus Partner Programme - which for the first time in history involves the opening of...